Mutant lamin A links prophase to a p53 independent senescence program

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Cellular senescence is a key anticancer mechanism involving p53 and RB tumor suppressor pathways.
• Most tumor cells evade senescence by mutating these critical pathways.
• Restoring senescence in p53-deficient tumors remains a therapeutic challenge.

Purpose of the Study:

• To investigate if a mutant lamin A protein can induce cellular senescence in p53-deficient cancer cells.
• To elucidate the molecular mechanisms by which mutant lamin A triggers senescence.
• To evaluate the therapeutic potential of inducing senescence in tumors.

Main Methods:

• Expression of a specific mutant lamin A allele in p53-deficient cells.
• Analysis of nuclear envelope structure, cell cycle progression, and DNA replication.
• Assessment of senescence markers, including inflammatory gene expression.
• In vivo tumorigenicity assays.

Main Results:

• Mutant lamin A accumulated due to impaired ZMPSTE24 processing and prevented nuclear envelope disassembly.
• This led to mitotic defects, nuclear fragmentation, and polyploidy.
• Cells arrested in interphase exhibiting senescence features, including inflammation.
• Tumorigenicity was significantly reduced in vivo.

Conclusions:

• A farnesylated mutant lamin A can bypass p53 deficiency to induce cellular senescence.
• Mutant lamin A disrupts mitosis and nuclear integrity, leading to a senescence-associated secretory phenotype.
• Targeting lamin A processing or modification presents a potential strategy for cancer therapy.